Highlander Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Highlander Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.25M	Sell	23,109 -200	-0.9%	-$10.2K	0.43%	51
2023 Q4	$1.2M	Buy	23,309 +1,160	+5%	+$60.9K	0.43%	54
2023 Q3	$1.29M	Buy	22,149 +1,407	+7%	+$86.2K	0.51%	45
2023 Q2	$1.33M	Buy	20,742 +250	+1%	+$16.8K	0.61%	37
2023 Q1	$1.42M	Sell	20,492 -166	-0.8%	-$11.7K	0.7%	32
2022 Q4	$1.49M	Hold	20,658	–	–	0.78%	30
2022 Q3	$1.47M	Sell	20,658 -716	-3%	-$51.9K	0.84%	28
2022 Q2	$1.65M	Sell	21,374 -150	-0.7%	-$11.4K	0.89%	28
2022 Q1	$1.57M	Hold	21,524	–	–	0.74%	33
2021 Q4	$1.34M	Buy	21,524 +700	+3%	+$41.1K	0.62%	39
2021 Q3	$1.23M	Hold	20,824	–	–	0.62%	40
2021 Q2	$1.39M	Sell	20,824 -3,550	-15%	-$231K	0.69%	35
2021 Q1	$1.54M	Buy	24,374 +3,850	+19%	+$240K	0.8%	33
2020 Q4	$1.27M	Hold	20,524	–	–	0.71%	33
2020 Q3	$1.24M	Hold	20,524	–	–	0.75%	33
2020 Q2	$1.21M	Hold	20,524	–	–	0.76%	36
2020 Q1	$1.14M	Hold	20,524	–	–	0.82%	30
2019 Q4	$1.32M	Sell	20,524 -3,000	-13%	-$172K	0.76%	35
2019 Q3	$1.19M	Hold	23,524	–	–	0.73%	35
2019 Q2	$1.07M	Hold	23,524	–	–	0.65%	42
2019 Q1	$1.12M	Sell	23,524 -1,600	-6%	-$79.7K	0.69%	38
2018 Q4	$1.31M	Hold	25,124	–	–	0.86%	26
2018 Q3	$1.56M	Sell	25,124 -2,000	-7%	-$119K	0.87%	23
2018 Q2	$1.5M	Buy	27,124 +5,200	+24%	+$281K	0.85%	23
2018 Q1	$1.36M	Buy	21,924 +16,500	+304%	+$1.06M	0.81%	28
2017 Q4	$332K	Sell	5,424 -11,450	-68%	-$716K	0.24%	110
2017 Q3	$1.08M	Sell	16,874 -3,000	-15%	-$175K	0.84%	18
2017 Q2	$1.12M	Buy	19,874 +1,550	+8%	+$84.3K	0.88%	16
2017 Q1	$996K	Buy	18,324 +11,000	+150%	+$603K	0.82%	23
2016 Q4	$428K	Sell	7,324 -250	-3%	-$13.7K	0.37%	76
2016 Q3	$408K	Buy	7,574 +1,200	+19%	+$77.1K	0.37%	72
2016 Q2	$469K	Hold	6,374	–	–	0.43%	65
2016 Q1	$407K	Hold	6,374	–	–	0.38%	69
2015 Q4	$438K	Hold	6,374	–	–	0.41%	64
2015 Q3	$377K	Sell	6,374 -1,000	-14%	-$63.4K	0.36%	73
2015 Q2	$491K	Sell	7,374 -1,500	-17%	-$98.9K	0.44%	60
2015 Q1	$572K	Hold	8,874	–	–	0.49%	48
2014 Q4	$524K	Sell	8,874 -2,500	-22%	-$141K	0.45%	56
2014 Q3	$582K	Hold	11,374	–	–	0.55%	41
2014 Q2	$552K	Buy	11,374 +1,000	+10%	+$49.3K	0.5%	54
2014 Q1	$539K	Hold	10,374	–	–	0.51%	49
2013 Q4	$551K	Hold	10,374	–	–	0.52%	46
2013 Q3	$480K	Buy	10,374 +1,250	+14%	+$54.9K	0.48%	51
2013 Q2	$408K	Buy	+9,124	New	+$396K	0.43%	58

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Highlander Capital Management's BMY Position: Q1 2024 in Review

Highlander Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 0.86% in Q1 2024, selling an estimated $10.2K and leaving 23,109 shares worth $1.25M. The position accounts for 0.43% of the portfolio, ranked #51.

Highlander Capital Management first reported a position in BMY in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.65M in Q2 2022. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Highlander Capital Management held 23,109 shares of Bristol-Myers Squibb worth $1.25M as of Q1 2024.
Highlander Capital Management sold 200 Bristol-Myers Squibb shares in Q1 2024, an estimated $10.2K.
Bristol-Myers Squibb made up 0.43% of Highlander Capital Management's portfolio in Q1 2024, its #51 holding.
Highlander Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 44 quarters since.
Highlander Capital Management's Bristol-Myers Squibb position peaked at $1.65M in Q2 2022.
2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.